Main Article Content

Muhammad Tayyab Naeem
Abdul Rauf
Fazal Ur Rehman
Abdul Razaq
Muhammad Yahya Hassan
Ahmed Hassan Usman



Background: Urinary tract infections (UTIs) acquired in the community or hospital are a common cause of urosepsis, which develops in 20% to 30% of sepsis patients. The SOFA score evaluates and rates the dysfunction of six different organ systems, including the respiratory system (including partial arterial oxygen pressure, fraction of inspired oxygen, and respiratory support), coagulation, platelet count, liver, cardiovascular, neurological, and renal systems (including creatinine and urine output).

Methadology: A prospective analysis including 55 patients admitted with a diagnosis of emphysematous pyelonephritis based on a CT scan was carried out in Shaikh Zayed Hospital, Lahore, from 2021 to 2022. Clinical information was acquired on patients who had a history of upper urinary tract blockage based on a CT scan and who were treated conservatively. Patients who had no prior history of organ failure at the time of presentation were given a SOFA score of 0, and the SOFA score is then assessed for all patients who were treated primarily with medications, ureteric stenting, and percutaneous drainage.

Results: Upper ureteric tract blockage (0.0204) and conservative management techniques such medications, ureteric stents, or PCD (0.001) are strongly related to changes in SOFA scores in patients with emphysematous pyelonephritis.

Conclusion: A decline in SOFA score corresponds to obstruction of the upper ureteric tract.In emphysematous pyelonephritis, percutaneous catheter drainage is far more effective than retrograde ureteric stenting at preventing the deterioration of the SOFA score.

Abstract 243 | PDF Downloads 85


1. Wagenlehner, F. M., Pilatz, A., Naber, K. G., & Weidner, W. (2008). Therapeutic challenges of urosepsis. European journal of clinical investigation, 38 Suppl 2, 45–49.
2. Brun-Buisson C. (2000). The epidemiology of the systemic inflammatory response. Intensive care medicine, 26 Suppl 1(Suppl 1), S64–S74.
3. Shokeir, A. A., El-Azab, M., Mohsen, T., & El-Diasty, T. (1997). Emphysematous pyelonephritis: a 15-year experience with 20 cases. Urology, 49(3), 343–346.
4. Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J. D., Coopersmith, C. M., Hotchkiss, R. S., Levy, M. M., Marshall, J. C., Martin, G. S., Opal, S. M., Rubenfeld, G. D., van der Poll, T., Vincent, J. L., & Angus, D. C. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801–810.
5. Moreno, R., Vincent, J. L., Matos, R., Mendonça, A., Cantraine, F., Thijs, L., Takala, J., Sprung, C., Antonelli, M., Bruining, H., & Willatts, S. (1999). The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive care medicine, 25(7), 686–696.
6. Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. The New England journal of medicine, 348(16), 1546–1554.
7. Koch, G. E., & Johnsen, N. V. (2021). The Diagnosis and Management of Life-threatening Urologic Infections. Urology, 156, 6–15.
8. Xu, Z. H., Yang, Y. H., Zhou, S., & Lv, J. L. (2021). Percutaneous nephrostomy versus retrograde ureteral stent for acute upper urinary tract obstruction with urosepsis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 27(2), 323–328.
9. Lee, J. H., Lee, Y. M., & Cho, J. H. (2012). Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 18(1), 130–133.
10. Reyner, K., Heffner, A. C., & Karvetski, C. H. (2016). Urinary obstruction is an important complicating factor in patients with septic shock due to urinary infection. The American journal of emergency medicine, 34(4), 694–696.
11. Seymour, C. W., Liu, V. X., Iwashyna, T. J., Brunkhorst, F. M., Rea, T. D., Scherag, A., Rubenfeld, G., Kahn, J. M., Shankar-Hari, M., Singer, M., Deutschman, C. S., Escobar, G. J., & Angus, D. C. (2016). Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 762–774.
12. Raith, E. P., Udy, A. A., Bailey, M., McGloughlin, S., MacIsaac, C., Bellomo, R., Pilcher, D. V., & Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE) (2017). Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit. JAMA, 317(3), 290–300.
13. Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., Rochwerg, B., Rubenfeld, G. D., Angus, D. C., Annane, D., Beale, R. J., Bellinghan, G. J., Bernard, G. R., Chiche, J. D., Coopersmith, C., De Backer, D. P., … Dellinger, R. P. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive care medicine, 43(3), 304–377.
14. Marshall, J. C., & al Naqbi, A. (2009). Principles of source control in the management of sepsis. Critical care clinics, 25(4), 753–ix.
15. Mosli, H. A., Farsi, H. M., al-Zimaity, M. F., Saleh, T. R., & al-Zamzami, M. M. (1991). Vesicoureteral reflux in patients with double pigtail stents. The Journal of urology, 146(4), 966–969.
16. Shao, Y., Shen, Z. J., Zhuo, J., Liu, H. T., Yu, S. Q., & Xia, S. J. (2009). The influence of ureteral stent on renal pelvic pressure in vivo. Urological research, 37(4), 221–225.
17. Hansen, M. H., Wang, B. Y., Afzal, N., Boineau, F. G., Lewy, J. E., & Shortliffe, L. M. (2003). Effect of urinary tract infection on ureteropelvic junction obstruction in a rat model. Urology, 61(4), 858–863.
18. Nevo, A., Mano, R., Baniel, J., & Lifshitz, D. A. (2017). Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU international, 120(1), 117–122.
19. Mokhmalji, H., Braun, P. M., Martinez Portillo, F. J., Siegsmund, M., Alken, P., & Köhrmann, K. U. (2001). Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. The Journal of urology, 165(4), 1088–1092.
20. Das, D., & Pal, D. K. (2016). Double J stenting: A rewarding option in the management of emphysematous pyelonephritis. Urology annals, 8(3), 261–264.
21. Somani, B. K., Nabi, G., Thorpe, P., Hussey, J., Cook, J., N'Dow, J., & ABACUS Research Group (2008). Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. The Journal of urology, 179(5), 1844–1849.
22. Borofsky, M. S., Walter, D., Shah, O., Goldfarb, D. S., Mues, A. C., & Makarov, D. V. (2013). Surgical decompression is associated with decreased mortality in patients with sepsis and ureteral calculi. The Journal of urology, 189(3), 946–951.

Most read articles by the same author(s)